References
- Yamashita M, Nonaka T, Arai T, Methylene blue and dimebon inhibit aggregation of TDP-43 in cellular models. FEBS Lett 2009;583:2419–24.
- Cortese I, Chaudhry V, So YT, Evidence-based guideline update: plasmapheresis in neurologic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2011;76:294–300.
- Raphael JC, Chastang C, Masson C, Guillain–Barre syndrome and plasma exchange. Lancet 1985;2:45.
- van Doorn PA, Kuitwaard K, Walgaard C, IVIG treatment and prognosis in Guillain-Barre syndrome. J Clin Immunol. 2010;30(Suppl 1):S74–8.
- Arai T, Hasegawa M, Akiyama H, TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 2006;351:602–11.
- Neumann M, Sampathu DM, Kwong LK, Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006;314:130–3.
- Brooks BR, Miller RG, Swash M, Munsat TL. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 2000;1:293–9.
- Nonaka T, Kametani F, Arai T, Truncation and pathogenic mutations facilitate the formation of intracellular aggregates of TDP-43. Hum Mol Genet 2009;18:3353–64.
- Lee HJ, Patel S, Lee SJ. Intravesicular localization and exocytosis of alpha-synuclein and its aggregates. J Neurosci 2005;25:6016–24.
- Nickel W, Rabouille C. Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol 2009;10:148–55.
- Foulds P, McAuley E, Gibbons L, TDP-43 protein in plasma may index TDP-43 brain pathology in Alzheimer's disease and frontotemporal lobar degeneration. Acta Neuropathol 2008;116:141–6.
- Foulds PG, Davidson Y, Mishra M, Plasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration. Acta Neuropathol 2009;118:647–58.
- Steinacker P, Hendrich C, Sperfeld AD, TDP-43 in cerebrospinal fluid of patients with frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Arch Neurol 2008;65:1481–7.
- Kasai T, Tokuda T, Ishigami N, Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Acta Neuropathol 2009;117:55–62.
- Noto Y, Shibuya K, Sato Y, Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value. Amyotroph Lateral Scler 2011;12:140–3.